|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Opioid Litigation: Evading the Widening Crosshairsalmost 8 years ago
Patient & Customer-Centric Commercializationalmost 8 years ago
Compliance: The Critical Cog in Pharma Machinealmost 8 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysalmost 8 years ago
A Seat at the Strategy Tablealmost 8 years ago
Regulatory Innovation Generates Breakthroughsalmost 8 years ago
China’s Biopharma Rise: Opportunities and ThreatsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
What Pharma Investors Should Expect in the Current Regulatory Environment
5